Eight 2-deoxystreptamine-negative (DOS-) mutants were isolated from various strains of Bacillus circulans, normally producing butirosin, xylostasin and ribostamycin.
2-Deoxystreptamine (DOS) is a widely distributed component of many important aminoglycoside
antibiotics, such as butirosin, xylostasin, ribostamycin, neomycin, kanamycin and gentamicin. However, the complete biosynthetic pathway has not been elucidated. RINEHART and STROSHANE1) proposed two pathways of DOS biosynthesis, based on the results of 13C-glucose and 13C-glucosamine incorporation into neomycin. DAUM, et al. 2. 3) examined the bioconversion of many synthesized cyclitols and aminocyclitols to gentamicins by a DOS-mutant of Micromonospora purpurea and supposed the pathway proposed by RINEHART, et al., to be borne out. Recently, FURUMAI, et al.') reported that 2-deoxyscyllo-inosose and 2-deoxy-scy/lo-inosamine were converted to butirosin by butirosin-non-producing blocked mutants of Bacillus circulans. However, they used racemic compounds in their experiments, so it seems that the true pathway was still uncertain. Along with tracer experiments, isolation and analysis of a blocked mutant are very effective approaches to the study of a biosynthetic pathway. We report here the isolation of some kinds of DOS-mutants from butirosin (BTN), xylostasin (XLN), or ribostamycin (RBM) producing strains of B. circulans. Isolation of an aminocyclitol, S-11-P, which seems to be a precursor in DOS biosynthesis was performed with one of the mutants (secretor). The detection and assay of S-11-P were carried out by using another class of DOS-mutant (converter) having the ability to transform S-11-P to BTN.
Materials and Methods
Strains DOS-mutants used in this experiment are listed in Table 1 . Isolation procedures of the parent strains of each mutant were reported in the previous paper''.
Cosynthesis by agar plate culture Two mutant strains were streaked on a production agar medium in a Petri dish containing 1.0% glycerol, 2.0 % Soytone (Difco), 0.3 % MgSO4,7H2O and 1.5 % agar, then incubated at 28°C for 5 days (Fig. 1) Cosynthesis by liquid culture Seed medium (S-4) containing 2.0 % soluble starch, 1.0 % tryptone (Difco), 1.0 % yeast extract (Difco), and 0.3%, MgSO4 .7H2O, (pH 7) was inoculated with a loooful of cells grown on a soybean agar slant and incubated at 28°C for 24 hours on a reciprocal shaker. Each 0.2 ml of the seed culture prepared by two mutant strains to be tested was simultaneously inoculated into 10 ml of fermentation medium (F-5) containing 3.0 % corn starch, 3.0 % oat meal, 2.0 % Polypepton, 0.3% MgSO4 .7H2O, and 1.0 % CaCO3. Antibiotic activity after 5 days culture at 28°C on a reciprocal shaker was assayed, and the product was purified by column chromatography using Amberlite IRC-50 (NH4+) and identified by TLC-bioautography.
Assay of an intermediate of DOS biosynthesis (S-11-P) For the assay of S-11-P, strain 236 was used. The assay procedure was essentially the same as in the case of cosynthesis by liquid culture. A 0.4-ml amount of seed culture of strain 236 was transferred into 10 ml of the production medium (F-5) and incubated for 24 hours on a reciprocal shaker. An S-11-P containing sample was supplemented to this culture broth and, after 4 days incubation, antibiotic activity was assayed with B. subtilis as test organism. A blank culture was made without the addition of S-11-P.
Fermentation and isolation of S-11-P A seed culture (medium S-4) of strain S-11 was used to inoculate to 20 liters of medium F-5 in a 30-liter jar fermenter. After 4 days fermentation at 28°C, the culture filtrate was adsorbed on Amberlite IRC-50 (NH4+). The material eluted with 1 N aqueous ammonia was again adsorbed on the column of the same resin. The S-11-P fraction eluted from the column with 1 N ammonia was concentrated under reduced pressure. The concentrate was purified by repeated chromatography using an Amberlite CG-50 (NH4+) column with linear gradient elution by ammonia (0-0.4 N), followed by passage through a column of Dowex 1 x 4 (OH-). The purified fraction containing S-11-P thus obtained was lyophilized and used for structure elucidation.
Results
Cosynthetic experiments on agar plates were performed by cultivating simultaneously 2 mutant Table 2 , we selected strain S-I1 (secretor) and strain 236 (converter) for further study to clarify the pathway of DOS biosynthesis. The culture circulans S-11. S-I1-P titer was expressed as arbitrary unit which obtained by BTN activity produced by strain 236. At the indicated times the sample was withdrawn from the fermentation of strain S-I1 in a jar fermenter. The sample was centrifuged and S-11-P titer was assayed as described in Materials and Methods. The titer of S-11-P 70 units at 4 days culture roughly corresponds to 420 pg/ml of pure S-I1-P base. filtrate of strain S-11 had the same effect as DOS for producing butirosin when it was added to a culture of strain 236 and fermented for several days. This DOS-like substance in the culture filtrate of strain S-11 was designated as S-11-P. The amount of S-11-P increased gradually up to 4 days in jar fermentation (Fig. 2) . As S-11-P was a basic, water soluble substance, it was isolated and purified as described in the Materials and Methods.
Physico-chemical properties of S-11-P sulfate are summarized in Table 3 . From these data, S-11-P was supposed to be a DOS-like substance, with one amino group replaced by a hydroxyl group.
`C NMR spectra of DOS (1) and S -11-P in D2O clearly show that the structure of S-11-P corresponds to 2 or its enantiomer (3) (Fig. 4 , Table 4 ). By comparison with chemically synthesized samples', S-11-P was identified as 2.
According to the IUPAC-IUB tentative cyclitol nomenclature rules'), S-11-P is named as (IL)-1,3,5/2,4-5-amino-cyclohexanetetrol. In relation to DOS and by the same numbering system as that of DOS (1), S-I1-P (2) is named as 1-deamino-2-deoxy-l-hydroxystreptamine.
S-I1-P was converted to BTNs A and B by strain 236, and the conversion rate was nearly equal to that of DOS. Chemically synthesized S-11-P6) was also converted to BTNs A and B by strain 236. Table 4 . 13C-Chemical shifts (d) of S-t I-P and 2-deoxystreptamine. 13C NMR spectra of DOS and S -11-P in D2O, and the structures of DOS (1), S-11-P (2), and the enantiomer (3) of S-II-P.
(1) 2-Deoxystreptamine (2) s-11-P
Discussion
We reported the isolation of xylostasinand ri bostamycin-producing mutants from the butirosin-THE JOURNAL OF ANTIBIOTICS AUG. 1980 producing strain of B. circulans B15M, by the cylinder culture and double indicator methods). Along with the isolation of these mutants, many antibiotic-non-producing mutants were simultaneously isolated. These mutants were further examined for antibiotic production using DOS-containing cultures. Eight DOS-mutants were isolated in this way. By a simple experiment on agar plate culture, the detection of cosynthetic pairs and the characterization of each mutant were carried out. The mutants were divided into two classes, secretor and converter. Cosynthetic behavior of the mutants in liquid medium and their secretor-converter characters were confirmed by identifying the product. Based on the above observation, we selected secretor strain S-11, and isolated S-1 1-P from the fermentation broth of this strain. S-11-P is a very important aminocyclitol, which was isolated from a DOS-mutant for the first time. S-11-P was converted to DOS and further to BTN or RBM, depending on converter strains. These facts give the direct evidence concerning the DOS biosynthetic pathway.
S-11-P corresponds to one of the intermediates of DOS biosynthesis postulated by RINEHART and STROSHANE' . DAUM, et al., found that by the supplementation of DL-2,4/3,5-tetrahydroxycyclohexanone in the culture medium, a DOS-mutant of Micromonospora purpurea produced gentamicins3), and by the addition of scyllo-inosamine-2, it produced 2-hydroxygentamicins2'.
FURUMAI, et al. 4) , found that DL-1,3,5/2,4-5-amino-cyclohexanetetrol, as well as DL-2,4/3,5-tetrahydroxycyclohexanone, were incorporated into BTNs by the mutants of B. circulans. From these data and from our results, we conclude that the upper line of Fig. 5 including S-11-P could be the true pathway of DOS biosynthesis, common to Streptomyces, Micromonospora and Bacillus.
Although the blockage in strain S-11 has still not been established, the dehydrogenation step seems to be a plausible one as illustrated in Fig. 5 , because S-11-P was accumulated in the culture broth of this strain. Another possibility is that the blockage could be at the transamination step, if the dehydrogenation step of S-11-P is reversible and the equilibrium is favored to S-1 1-P as in the case of myo-inositol 2-dehydrogenasee). On the other hand, the blockage in strain 236 is supposed to be at a nearer step to glucose, because by the addition of scyllo-inosose to a culture of this strain, it produced a 2-hydroxybutirosin-like antibiotic. The structures in the parenthesis are intermediates proposed by RINEHART and STROSHANE, but no experimental evidence has been obtained.
